- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05112458
Cope 360 App for Caregivers of Children With Cancer
Pilot Randomized Control Trial of Cope 360 App for Caregivers of Children With Cancer
To date, most caregiver focused interventions have been targeted at caregivers of adults with cancer, completely ignoring the unique needs of caregivers of children with cancer. A recent meta-analysis indicated that although these interventions had small to medium effects, they significantly reduced burden, improved ability to cope, increased self-efficacy, and improved aspects of caregivers' quality of life. Yet, several recent reviews highlighted a lack of interventions to provide practical skills for the day-to-day provision of care. The investigators have developed a pediatric oncology caregiver-focused intervention that seeks to improve caregiver clinical skills/knowledge, self-efficacy, and support seeking skills.
Cope 360 is a mHealth (mobile health) app designed to support caregivers of children with cancer with symptom tracking, medication management, and emergency preparedness. The investigators propose to evaluate Cope 360 via a pilot, randomized control trial in which some caregivers will receive the app and some will not. The purpose of this study is to assess: 1) feasibility of caregiver use over extended period of time, 2) acceptability of the mHealth tool by caregivers in a real-world setting, 3) impact of the mHealth tool on caregiver self-efficacy, mastery of caregiving skills/knowledge, and caregiver stress, and 4) effect on healthcare utilization of the child with cancer (i.e. preliminary data about sick visits and ED encounters).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Procedure: The investigators will identify approximately 164 primary caregivers of children with cancer, 82 for both the intervention group and the usual care group. Those in the intervention group will be presented with the mHealth app and with the help of the RA, the participants will download the app onto their personal smartphone. Participants will be asked to use the app for a 6-month period of time. They will also receive standardized education that is provided to all caregivers of newly diagnosed patients at the investigator's institution. Those in the usual care group will receive standardized education. These caregivers will NOT be provided with access to the app.
After a participant has been enrolled in the study, the RA will collect demographic and contact information and will administer baseline assessments. Follow-up surveys with a unique identifier will be administered via email at 1, 3 and 6 months for caregivers in both the intervention and control groups. If a survey is not completed, the RA will attempt to contact the participant by phone. Surveys will be administered via Qualtrics. The investigators will collect data via these surveys on participant demographics and mobile technology usage, and outcomes will be measured utilizing the following assessments: the Caregiver Self-Efficacy scale, Caregiver Mastery scale, Pediatric Inventory for Parents, and the Technology Acceptance Model. Semi-structured interviews will be done with a subset of participants in the intervention group at the 6-month mark. Intervention participants will be contacted by phone or email and asked to participate in the interview until a subset of 30 is reached. Interviews will be conducted in person, by phone, or by Zoom videoconferencing depending on the clinic schedule of the participant's child.
Randomization: Caregivers will be randomized into either the intervention group or the usual care group. Randomization tables will be generated with SAS v9.4 utilizing the PROC PLAN procedure.
Data Collection and Analysis: Data will be collected on a variety of socio-demographic factors that have been hypothesized to impact acceptability and use of technology: age, education, gender, race, income, prior experience/exposure/awareness with computer or health technology. Information gathered will also include basic information about their child's cancer diagnosis including: type of cancer, date of diagnosis, and type of treatment protocol. Semi-structured interviews will transcribed and analyzed using Nvivo qualitative research software. Survey data will be analyzed with SAS v9.4, Qualtrics, and Microsoft Excel.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Emily L Mueller, MD
- Phone Number: 317-944-2143
- Email: elmuelle@iu.edu
Study Contact Backup
- Name: Anneli R Cochrane, MPH
- Phone Number: 317-278-9695
- Email: arcochra@iupui.edu
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- English-speaking (app is in English)
- Caregiver (parent, legal guardian, grandparent, etc.) to a child with cancer
- Caregiver to a child with cancer currently undergoing therapy (chemotherapy, radiation, etc.)
- Caregiver to a child with cancer who anticipates therapy to continue for 6 months after recruitment
- Caregiver to a child with cancer between the ages of 0 and 21 years old
- Must own a smartphone or other internet capable mobile device
Exclusion Criteria:
- Non-English speaking (app is in English)
- Caregiver with a child with cancer who is not currently undergoing therapy
- Caregiver to a child with cancer who does not anticipate therapy to continue for 6 months after recruitment
- Caregiver with a child over age 21
- Caregiver who do not own a smartphone or other internet capable mobile device
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cope 360 application
Participants are given access to the application and will use it to care for their child with cancer for a period of 6 months.
|
Cope 360 is a mHealth (mobile health) app designed to support caregivers of children with cancer with symptom tracking, medication management, and emergency preparedness.
We will evaluate Cope 360 via a pilot, randomized control trial in which some caregivers will receive the app and some will not.
The purpose of this study is to assess: 1) feasibility of caregiver use over extended period of time, 2) acceptability of the mHealth tool by caregivers in a real-world setting, 3) impact of the mHealth tool on caregiver self-efficacy, mastery of caregiving skills/knowledge, and caregiver stress, and 4) effect on healthcare utilization of the child with cancer (i.e.
preliminary data about sick visits and ED encounters).
|
Active Comparator: Usual Care
Participants are given usual care and not given access to the application.
They will be surveyed along with the experimental group for a period of 6 months.
|
Caregivers of children with cancer will receive the usual clinical care provided to our patient population.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Technology Feasibility Scale Rating
Time Frame: 6 months
|
Feasibility of participant use over an extended period of time; measured using the Technology Acceptance Model (TAM).
|
6 months
|
Qualitative Technology Feasibility
Time Frame: 6 months
|
Feasibility of participant use over an extended period of time; measured using semi-structured qualitative interviews.
|
6 months
|
Data Log User Acceptability
Time Frame: 6 months
|
Acceptability by caregivers in a real-world setting; measured using audits of usage data and recorded or reported errors from data logs.
|
6 months
|
Self-Efficacy Scale Rating
Time Frame: 6 months
|
Caregiver self-efficacy, measured using the Caregiver Self-Efficacy scale.
|
6 months
|
Mastery of Caregiving Scale Rating
Time Frame: 6 months
|
Mastery of caregiving skills/knowledge; measured using the the Caregiver Mastery scale.
|
6 months
|
Stress Reduction Scale Rating
Time Frame: 6 months
|
Reduction in caregiver stress; measured using the Pediatric Inventory for Parents assessment scale.
|
6 months
|
Healthcare Utilization Effect
Time Frame: 6 months
|
Effect on healthcare utilization of the child with cancer (i.e.
preliminary data about sick visits and ED encounters).
|
6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Emily L Mueller, MD, Indiana University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 11097
- 5K08CA230218-04 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Cancer
-
Emory UniversityNational Cancer Institute (NCI)Recruiting
-
Ann & Robert H Lurie Children's Hospital of ChicagoSilicon Valley Community FoundationUnknownCancer | Pediatric CancerUnited States
-
University of BirminghamCompletedCancer | Pediatric ALL | Pediatric Solid Tumor | Pediatric AMLUnited Kingdom, Australia, Netherlands
-
Alexandria UniversityCompletedPediatric Cancer | Invasive CancerEgypt
-
University of California, San DiegoNational Cancer Institute (NCI); Dana-Farber Cancer Institute; University of... and other collaboratorsNot yet recruiting
-
Immune Oncology Research InstituteRecruitingContinuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With DexamethasonePediatric CancerArmenia
-
Connecticut Children's Medical CenterThe Hospital for Sick ChildrenRecruitingPediatric CancerUnited States
-
University of Michigan Rogel Cancer CenterRecruitingPediatric CancerUnited States
-
Erin RowellRecruiting
-
Giselle ShollerRecruiting
Clinical Trials on Cope 360 mobile health application
-
San Diego State UniversityRecruitingObesity | Diabetes Mellitus, Type 2United States
-
Vanderbilt University Medical CenterOhio State UniversityActive, not recruitingSickle Cell DiseaseUnited States
-
San Diego State UniversityRecruitingObesity | Diabetes Mellitus, Type 2United States
-
University of CadizCompleted
-
University of LincolnLincolnshire Partnership NHS Foundation TrustCompletedPsychological DistressUnited Kingdom
-
Hospital Clinic of BarcelonaCompletedChronic Disease | Multiple Chronic ConditionsSpain
-
University of California, San FranciscoNational Institute of Mental Health (NIMH)CompletedHIV/AIDS | Mobile Health | Young AdultsUnited States
-
University of California, Los AngelesCompletedContraception | Mobile Applications | Contraception BehaviorUnited States
-
University of MinnesotaCompletedHealthy Children (1 Month to 17 Years Old)United States
-
Gazi UniversityCompletedPregnant Women | Mobile Applications | Adaptation | Postpartum PeriodTurkey